BMI View: South Africa will continue to be one of the most important markets in Africa for pharmaceutical companies, medical device companies and healthcare provider s due to its economics of scale. This report provides an overall view of healthcare resources, demographic changes, and public/private investment in the sector within South Africa's nine provinces .
South Africa is the largest economy on the African continent, with a population of 53 million and a gross domestic product (GDP) that tripled between 2002 and 2013. It also belongs to the 'BRICS' group of emerging world markets. The majority of the South African population resides in the north east and south west parts of the country. While the number of hospitals in each province tends to be roughly proportional to regional population figures, the degree of public and private healthcare provision varies depending on a province's level of economic development (gross state product per capita) and, to some extent, the burden of HIV/AIDS and other infectious diseases including cholera and malaria.
5.4 million people in South Africa over the age of 15 are estimated to be carriers of the HIV virus. Combating the spread of aids is an ongoing battle. The prevalence of infectious diseases, unmet medical needs, and growing economic prosperity make South Africa an attractive healthcare market for pharmaceutical companies. This report provides an overall view of healthcare trends and forecasts within South Africa's nine provinces.
More than half of South Africa's population resides within the north east provinces of Gauteng and Kwa-Zulu Natal and the coastal province of the Eastern Cape. Gauteng has the largest share of the population followed by KwaZulu-Natal and Eastern Cape. These regions have the largest number of hospitals, a pattern we observe across the country. Gauteng is the business hub, boasting the highest absolute and per capita gross state product. It is bordered by provinces whose...